文献速递中医骨伤中药与中成药合理使用

Periplocin靶向LRP4调控代谢稳态与抗炎治疗椎间盘退变

Periplocin targets LRP4 to regulate metabolic homeostasis and anti-inflammation for the treatment of IVDD.
PubMed 文献 · Phytomedicine · 2025-05-22

本研究探讨Periplocin对椎间盘退变(IVDD)的作用机制与潜在靶点。通过大鼠IVDD模型及人髓核细胞实验,发现Periplocin抑制TNF-α诱导的炎症、减少基质降解并促进基质合成,且LRP4为其潜在靶点,提示Periplocin可能成为IVDD的潜在治疗药物。

要点

  • Periplocin抑制TNF-α诱导的炎症,减轻椎间盘退变进展。
  • Periplocin减少髓核细胞外基质降解并促进基质合成代谢。
  • LRP4是Periplocin发挥保护作用的关键潜在靶点。

核心结论

  • Periplocin可能通过抗炎、抑制细胞外基质降解和促进基质合成代谢来缓解椎间盘退变,LRP4是其潜在作用靶点。

研究设计与样本

  • 研究采用针刺法建立大鼠椎间盘退变模型,并对退变椎间盘进行番红O-固绿和苏木精-伊红染色分析。
  • 从椎间盘退变患者和实验动物中提取髓核细胞,用于体外实验。
  • 采用蛋白质印迹、qRT-PCR、免疫荧光、阿利新蓝染色和免疫组化等技术评估炎症相关蛋白、mRNA及细胞外基质代谢。
  • 通过分子对接实验阐明Periplocin与LRP4的结合位点,并利用小干扰RNA敲低和过表达载体改变髓核细胞中LRP4表达以验证靶点。

主要发现

  • Periplocin抑制TNF-α诱导的炎症反应。
  • Periplocin减少基质降解。
  • Periplocin促进基质合成代谢并调控代谢稳态。
  • LRP4作为潜在靶点参与上述多条通路以保护椎间盘。

临床怎么用

  • Periplocin可能作为椎间盘退变的潜在治疗选择,具有抗炎、防止细胞外基质降解和促进基质合成代谢的益处。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intervertebral disc degeneration (IVDD) is characterized by deteriorating intervertebral discs, leading primarily to low back pain and leg pain. Most current treatments for IVDD primarily address symptoms without targeting the underlying degenerative process. Moreover, tumor necrosis factor-α (TNF-α)-mediated inflammation and degradation of the nucleus pulposus (NP) extracellular matrix (ECM) influence this pathological process. Periplocin, a cardiotonic steroid extracted from periplocin forrestii, has demonstrated a wide range of medical benefits, including cardiotonic, anticancer, anti-inflammatory, and wound healing properties. Nevertheless, the effects of periplocin on IVDD remain unexplored. OBJECTIVE: Our study explores the mechanism of action and the potential target of periplocin in mitigating IVDD pathology. METHODS: Rat models of IVDD were established using acupuncture, and the affected discs underwent analysis via Safranin O-Fast Green (S-O) and Hematoxylin and Eosin (H&E) staining. Nucleus pulposus cells (NPCs) were harvested from IVDD patients and experimental animals for examination. A variety of techniques, including Western blot analysis, quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) assay, immunofluorescence staining, Alcian Blue staining and Immunohistochemistry (IHC) staining, were utilized to evaluate inflammation-related proteins, mRNAs and the ECM metabolism. In order to ascertain the potential protein targets of periplocin, the binding site of periplocin to LRP4 was elucidated through the utilisation of molecular docking experiments. Subsequently, the expression of low-density lipoprotein receptor-related protein 4 (LRP4) in NPCs was modified through the use of small interfering RNA (siRNA) knockdown and overexpression vectors, which were employed for the purposes of target validation. RESULTS: We conclude from the present study that periplocin alleviates the progression of IVDD mainly through the following aspects: periplocin inhibits TNF-α-induced inflammatory; periplocin reduces matrix degradation; periplocin promotes matrix anabolism and regulates metabolic homeostasis. Moreover, the present study demonstrates that LRP4 is involved as a potential target in the multiple pathways mentioned above to protect the intervertebral disc. CONCLUSION: Our research suggests that periplocin may serve as a promising treatment for IVDD, offering anti-inflammatory benefits, preventing ECM degradation, and promoting ECM anabolism.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Liu Z, Qiao F, Liu D, et al. Periplocin targets LRP4 to regulate metabolic homeostasis and anti-inflammation for the treatment of IVDD. Phytomedicine. 2025. PMID: 40440911. doi:10.1016/j.phymed.2025.156885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。